Los Angeles Capital Management
CRMD icon

Los Angeles Capital Management’s CorMedix CRMD Stock Holding History

Los Angeles Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.56K Hold
581
– – ﹤0.01% 2146
2026
Q1 		$3.94K Sell
581
-60,974
-99% -$451K ﹤0.01% 2187
2025
Q4 		$715K Buy
61,555
+23,760
+63% +$263K ﹤0.01% 760
2025
Q3 		$440K Buy
+37,795
New +$457K ﹤0.01% 979

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Los Angeles Capital Management's CRMD Position: Q2 2026 in Review

Los Angeles Capital Management held its CorMedix (CRMD) position steady in Q2 2026 at 581 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

Los Angeles Capital Management first reported a position in CRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $715K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Los Angeles Capital Management held 581 shares of CorMedix worth $4.56K as of Q2 2026.
  • Los Angeles Capital Management left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2146 holding.
  • Los Angeles Capital Management first reported a position in CorMedix in Q3 2025 and has held it in 4 quarters since.
  • Los Angeles Capital Management's CorMedix position peaked at $715K in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.